BECTON DICKINSON & CO (BDX)
Clinical trial NCT06822036 updates: 1. primary completion date: 2026-01-30 → 2027-01-30 2. enrollment: not set → 362 participants
Clinical trial NCT06822036 updates: 1. primary completion date: 2026-01-30 → 2027-01-30 2. enrollment: not set → 362 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical